First biosimilar insulin launches

on the 2 September 2015

Abasaglar is a new biosimilar version of the long-acting insulin glargine (Lantus).

KwikPen delivers 1 to 60 units of insulin in single-unit increments.
KwikPen delivers 1 to 60 units of insulin in single-unit increments.

Further information
View Abasaglar drug record
Summary of Product Characteristics
Manufacturer: Eli Lilly

Like Lantus, Abasaglar is given once daily and is licensed for use in patients from the age of 2 years. It is available as a prefilled KwikPen or as cartridges for use in the reusable HumaPen and Autopen Classic devices.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

The most up-to-date drug information at your fingertips.

  • Get the prescribing support you need.
  • Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Register Now
Already Registered?

Forgotten password?

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Twitter